Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1976 Jun;52(608):381–388. doi: 10.1136/pgmj.52.608.381

Use of temperature-sensitive mutants of influenza A virus as live virus vaccine strains. Evaluation in laboratory animals, adults and children

Brian R Murphy, Douglas D Richman, Susan B Spring, Robert M Chanock
PMCID: PMC2496312  PMID: 785430

Abstract

Temperature-sensitive (ts) recombinants of influenza A virus were evaluated for use in a live virus vaccine. Evidence from several sources suggested that the ts lesions were responsible for attenuation of these mutants. Specification of attenuation by defined genetic lesions which can be assayed for in the laboratory offers an advantage to the use of ts viruses for vaccination. This means that ts recombinants can be assessed for genetic stability during vaccine development, production and later during usage in man. One ts virus, influenza A/Hong Kong/68-ts-1[E], with a 38°C shut-off temperature, had the following properties desirable for a live virus vaccine: (1) satisfactory infectivity for seronegative (serum HI antibody titre ≤ 1:8) adults; (2) satisfactory attenuation for adults; (3) capacity to stimulate local and serum anti-haemagglutinin and anti-neuraminidase antibodies in seronegative volunteers; (4) stimulation of resistance to virulent, wild type virus; (5) relative genetic stability in vivo; (6) lack of communicability in man; (7) replication to high titre in avian leucosis virus-free eggs; and (8) localization of ts lesions to genes that do not code for the haemagglutinin and neuraminidase. The ts lesions of influenza A/Hong Kong/68-ts-1[E] virus were transferred to more current viruses within the H3N2 subtype (influenza A/Udorn/307/72 and influenza A/Georgia/101/74). These recombinant Udorn/72 and Georgia/74 ts viruses, which possessed the same shut-off temperature and the same ts lesions as the influenza A/Hong Kong/68-ts-1[E] parent virus, exhibited a pattern of infection and attenuation in hamsters and man similar to their ts parent. These data suggest that ts mutants which are sufficiently attenuated for man, could serve as donors of ts lesions for the rapid production of an attenuated vaccine when new antigenic variants arise.

When the influenza A/Hong Kong/68-ts-1[E] virus was administered to children who lacked both anti-haemagglutinin and anti-neuraminidase antibody the virus replicated for a longer period than in adults and mild fever developed in some of the young vaccinees. A minority of children shed wild type revertant virus. The emergence of wild type virus in children, but not in adults, probably reflected the more extensive replication of the virus in the doubly seronegative children. The implications of these findings to the development and testing of live influenza A virus vaccines were discussed.

Full text

PDF
381

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Foy H. M., Cooney M. K., McMahan R. A Hong Kong influenza immunity three years after immunization. JAMA. 1973 Nov 12;226(7):758–761. [PubMed] [Google Scholar]
  2. Hall C. E., Cooney M. K., Fox J. P. The Seattle virus watch. IV. Comparative epidemiologic observations of infections with influenza A and B viruses, 1965-1969, in families with young children. Am J Epidemiol. 1973 Nov;98(5):365–380. doi: 10.1093/oxfordjournals.aje.a121566. [DOI] [PubMed] [Google Scholar]
  3. Hennessy A. V., Davenport F. M. Vaccination of infants against influenza with polyvalent influenza hemagglutinin. JAMA. 1967 Jun 5;200(10):896–898. [PubMed] [Google Scholar]
  4. Hirst G. K. Mechanism of influenza recombination. I. Factors influencing recombination rates between temperature-sensitive mutants of strain WSN and the classification of mutants into complementation--recombination groups. Virology. 1973 Sep;55(1):81–93. doi: 10.1016/s0042-6822(73)81010-4. [DOI] [PubMed] [Google Scholar]
  5. Maassab H. F. Biologic and immunologic characteristics of cold-adapted influenza virus. J Immunol. 1969 Mar;102(3):728–732. [PubMed] [Google Scholar]
  6. Mackenzie J. S. Virulence of temperature-sensitive mutants of influenza virus. Br Med J. 1969 Sep 27;3(5673):757–758. doi: 10.1136/bmj.3.5673.757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. McCahon D., Schild G. C. Segregation of antigenic and biological characteristics during influenza virus recombination. J Gen Virol. 1972 Apr;15(1):73–77. doi: 10.1099/0022-1317-15-1-73. [DOI] [PubMed] [Google Scholar]
  8. Mills J., Chanock R. M., Alling D. W. Mutants of influenza virus. Br Med J. 1969 Dec 13;4(5684):690–690. doi: 10.1136/bmj.4.5684.690-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Mills J., Chanock V., Chanock R. M. Temperature-sensitive mutants of influenza virus. I. Behavior in tissue culture and in experimental animals. J Infect Dis. 1971 Feb;123(2):145–157. doi: 10.1093/infdis/123.2.145. [DOI] [PubMed] [Google Scholar]
  10. Monto A. S., Davenport F. M., Napier J. A., Francis T., Jr Effect of vaccination of a school-age population upon the course of an A2-Hong Kong influenza epidemic. Bull World Health Organ. 1969;41(3):537–542. [PMC free article] [PubMed] [Google Scholar]
  11. Murphy B. R., Chalhub E. G., Nusinoff S. R., Chanock R. M. Temperature-sensitive mutants of influenza virus. II. Attenuation of ts recombinants for man. J Infect Dis. 1972 Aug;126(2):170–178. doi: 10.1093/infdis/126.2.170. [DOI] [PubMed] [Google Scholar]
  12. Murphy B. R., Chalhub E. G., Nusinoff S. R., Kasel J., Chanock R. M. Temperature-sensitive mutants of influenza virus. 3. Further characterization of the ts-1(E) influenza A recombinant (H3N2) virus in man. J Infect Dis. 1973 Oct;128(4):479–487. doi: 10.1093/infdis/128.4.479. [DOI] [PubMed] [Google Scholar]
  13. Murphy B. R., Hodes D. S., Nusinoff S. R., Spring-Stewart S., Tierney E. L., Chanock R. M. Temperature-sensitive mutants of influenza virus. V. Evaluation in man of an additional ts recombinant virus with a 39 C shutoff temperature. J Infect Dis. 1974 Aug;130(2):144–149. doi: 10.1093/infdis/130.2.144. [DOI] [PubMed] [Google Scholar]
  14. Murphy B. R., Spring S. B., Richman D. D., Tierney E. L., Kasel J., Chanock R. M. Temperature-Sensitive mutants of influenza virus. VII. Transfer of the TS-1[E] lesions to a wild-type influenza A virus with the HON1 surface antigens. Virology. 1975 Aug;66(2):533–541. doi: 10.1016/0042-6822(75)90225-1. [DOI] [PubMed] [Google Scholar]
  15. Richman D. D., Murphy B. R., Spring S. B., Coleman M. T., Chanock R. M. Temperature sensitive mutants of influenza virus. IX. Genetic and biological characterization of TS-1[E] lesions when transferred to a 1972 (H3N2) influenza A virus. Virology. 1975 Aug;66(2):551–562. doi: 10.1016/0042-6822(75)90227-5. [DOI] [PubMed] [Google Scholar]
  16. Spring S. B., Nusinoff S. R., Mills J., Richman D. D., Tierney E. L., Murphy B. R., Chanock R. M. Temperature-sensitive mutants of influenza virus. VI. Transfer of TS lesions from the Asian subtype of influenza A virus (H2N2) to the Hong Kong subtype (H3N2). Virology. 1975 Aug;66(2):522–532. doi: 10.1016/0042-6822(75)90224-x. [DOI] [PubMed] [Google Scholar]
  17. Spring S. B., Nusinoff S. R., Tierney E. L., Richman D. D., Murphy B. R., Chanock R. M. Temperature-sensitive mutants of influenza. VIII. Genetic and biological characterization of TS mutants of influenza virus A (H3N2) and their assignment to complementation groups. Virology. 1975 Aug;66(2):542–550. doi: 10.1016/0042-6822(75)90226-3. [DOI] [PubMed] [Google Scholar]
  18. Sugiura A., Tobita K., Kilbourne E. D. Isolation and preliminary characterization of temperature-sensitive mutants of influenza virus. J Virol. 1972 Oct;10(4):639–647. doi: 10.1128/jvi.10.4.639-647.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES